"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Original article
peer-reviewed

Frequency and Causes of Deferral among Blood Donors Presenting to Combined Military Hospital Multan



Abstract

Background & Aim

It is of great importance to carefully choose appropriate donors according to strict eligibility criteria, so as to guarantee an adequate and safe blood supply. The aim of this study was to determine the rate of deferral in blood donors and evaluate the different causes of deferral in Multan.

Materials & Methods

This prospective study was carried out at the Blood Bank of Combined Military Hospital (CMH) Multan. All donors who came for the donation of blood from 1st February to 30th September 2019 were evaluated after taking their consent. The data was analyzed to determine the frequency and causes of deferral using Statistical Package for the Social Sciences (SPSS) version 20.

Results

Among 3348 individuals presenting for blood donation, 433 (12.9%) were deferred (427 males and only six females). The mean age of deferred individuals was 28.96 + 6.42 years. The youngest individual was 18 years, while the eldest one was 51 years of age. Almost 65% of the individuals were less than 30 years of age. The most frequent cause of deferral was low hemoglobin. Anemia was the leading cause of deferral in more than half of the individuals (= 221). Hepatitis C virus (HCV) infection was the second most frequent cause of deferral, seen in 83 (19.2%), followed by hepatitis B virus (HBV) infection (= 49, 11.3%), syphilis (= 36, 8.3%), thrombocytopenia (= 18, 4.2%), and active infection (= 14, 3.2%). Other rarer causes included early donation, thrombocytosis, polycythemia, pancytopenia, malaria, allergies, insulin, and tuberculosis.

Conclusion

Deferral for blood donation is a significant problem in Multan and accounts for almost 13% of all prospective blood donors. Our results stress the importance of addressing the problem of anemia which is the most prevalent cause of temporary deferral for blood donation in this region of the world.

Introduction

Blood transfusion is an essential life-saving procedure. Its inpatient use for a variety of medical and surgical etiologies is increasing day by day. Approximately 85 million units of red blood cells (RBCs) are transfused globally per year [1]. According to another report, there is an overall 85.8% increase in the blood transfusion for the patients admitted in the hospitals from 2000 to 2013 [2]. This has led to an increased demand for blood donors to meet this requirement. Apart from this, there are significant benefits to blood donors’ health. There is a reported decrease in cardiovascular risk in blood donors as compared to non-donors [3-4]. Also, it is found to be protective against cancer, insulin resistance, and plaque rupture [5-8]

Blood donors could be voluntary, paid, or replacement donors who are usually close contacts of patients [9]. For the welfare and safety of donors and recipients, a thorough clinical and laboratory screening is done. On the basis of these results, some of the donors can be temporary or permanently deferred. This is not only frustrating for the donors but also for the healthcare professionals and societies involved in blood collection. The common causes of temporary deferral include low hemoglobin, infections including malaria, and duration of last blood donation less than three months. The donors could be permanently deferred due to underlying chronic conditions [10]

Multiple studies are conducted in different regions of the world to investigate the rates of blood deferral and its common etiologies. Our study aimed to comprehensively analyze the deferral rates, the different causes of deferral and donor characteristics of individuals presenting to Combined Military Hospital (CMH), Multan which is one of the largest centers in South Punjab, Pakistan.

Materials & Methods

This prospective study involved all individuals who presented for blood donation from February 1, 2019 to September 30, 2019 at the Blood Bank of Combined Military Hospital (CMH), Multan after taking approval from the Institutional Ethical Review Board. Informed consent was taken from all blood donors. 

All persons coming for blood donation were first counseled upon the process of blood donation by trained medical professionals. Then using a standardized questionnaire, the socio-demographic characteristics (age, gender, marital status, address) of participants were recorded. Inquiry about past diseases was made from all individuals. Measurements for weight and blood pressure were made. A complete blood examination was then undertaken. 

Testing for Human Immunodeficiency Virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), malaria and syphilis was done. Participants who do not fulfill the selection criteria for the donation were then deferred either temporarily or permanently depending on the reason for the deferral. The data was analyzed to determine the frequency and causes of deferral using SPSS version 20.
 

Results

Out of the 3348 individuals who came for blood donation during the study period, 433 (12.9%) were deferred. The majority of deferred individuals were males (n=427, 98%). There were only 6 female participants who were deferred. The mean age of the deferral group was 28.96 years with a standard deviation (SD) of 6.42 years. The youngest individual was 18 years, while the eldest one was 51 years of age. The majority of the deferred individuals belonged to the 21-30 years age group. Almost 65% of the individuals were less than 30 years of age. The different characteristics of the deferred participants are shown in Table 1.

Characteristics N (%)
Age (years)  
     Mean 28.96
     Standard Deviation 6.42
     Range 18-51
Gender  
     Male 427 (98.6)
     Female 6 (1.4)
Age Groups (years)  
     < 20 27 (6.2)
     21-30 194 (44.8)
     31-40 101 (23.3)
     41-50 16 (3.7)
     > 50 1 (0.2)
Hemoglobin (g/dl)  
     Mean 13
     Standard Deviation 1.72
     Range 7.2-17.5

The most frequent cause of deferral was low hemoglobin. Anemia was the leading cause of deferral in more than half of the individuals (= 221, 50.3%). Hepatitis C virus (HCV) infection was the second most frequent cause of deferral, seen in 83 (19.2%), followed by hepatitis B virus (HBV) infection (= 49, 11.3%), syphilis (= 36, 8.3%), thrombocytopenia (= 18, 4.2%), and active infection (= 14, 3.2%). Other rarer causes included too early donation, thrombocytosis, polycythemia, pancytopenia, malaria, allergies, insulin, and tuberculosis. The different causes of deferral are listed in Table 2.

Causes n (%)
Anemia* 218 (50.3)
HCV 83 (19.2)
HBV 49 (11.3)
Syphilis 36 (8.3)
Thrombocytopenia** 15 (3.5)
Active Infection 14 (3.2)
Anemia + Thrombocytopenia 3 (0.7)
HBV + Syphilis 3 (0.7)
Malaria 3 (0.7)
Polycythemia*** 2 (0.5)
HCV + Syphilis 1 (0.2)
Too early Donation**** 1 (0.2)
Thrombocytosis 1 (0.2)
Pancytopenia 1 (0.2)
Allergy 1 (0.2)
Insulin dependent diabetes mellitus 1 (0.2)
TB 1 (0.2)

Discussion

Blood donor selection is a key step in the transfusion process and usually comprises multiple checkpoints to ensure the safety of donors as well as the recipients. This process usually constitutes four steps. The first step includes sharing of knowledge about common infections that are transmissible during transfusion and other risks for a donor. This is followed by a donor health questionnaire that is completed by the donor and an interview by a permitted health professional (HP). Finally, the health of the donor is evaluated on the basis of physical and laboratory test results, which leads to acceptance or deferral of the donors. The deferral can be temporary or permanent depending upon the underlying condition. In our study, we aimed to find the frequency and common causes of deferrals among the blood donors [11].

Our study demonstrated a deferral rate of 12.9%. This is quite similar to a study conducted by Valerian et al. in northern Tanzania (12.7%) [12]. Another research study evaluating American Red Cross donation data showed a similar deferral rate (12.8%) [13]. But this is relatively high compared to some studies, conducted in the south region of Pakistan, Western India, and Malaysia which depicted deferral rates of 8.39%, 11.6%, and 5.6% respectively [14-16]. This contrast can be attributed to differences in sample size, demographic profile, and research methodology.

Low hemoglobin was found to be the most common cause of deferral (50.3%). This is comparable to other studies. A study carried out, using a structured questionnaire in 19 licensed blood banks of Pakistan, also manifested anemia as the leading cause of deferral (41%) [17]. Valerian et al. also demonstrated anemia as the common cause of temporary deferrals but the incidence was relatively lower (21.1%) [12]. Rabeya et al. showed 40.7% cases of deferrals due to low hemoglobin being predominantly females, but in our study, only 1.4% of the deferred cases were females [16]. In contrast to our results, a single-center study conducted in one of the blood centers in Pakistan showed therapeutic injections as the significant reason for blood donor deferrals, with low hemoglobin being second in the list [18]. An interesting study was conducted in South Pakistan to assess the deferral pattern on the basis of the peripheral count. It still showed anemia as the leading cause but depicted higher rates of polycythemia (3.3%) as opposed to our results (0.5%). By contrast, thrombocytopenia rates were higher in our study (3.5% versus 1.0%) [14].

The recommended cut-off for blood donation deferral is 12.5 g/dl, which implies that the donors with hemoglobin levels less than 12.5 g/dl are deferred irrespective of their demographic profile [19]. An extensive study was conducted in the United States to determine the association between the demographics and low hemoglobin in blood donor deferrals. It demonstrated female gender, advanced age in males and African-Americans, being significantly associated factors [20]. Our study comprised 98.6% males in the blood donor deferral group, and the mean age of the sample population was 28.96 years.

Hepatitis C infection was second among the common causes of a donor deferral (19.2%) but first in the list of infections. This was followed by hepatitis B virus infection (11.3%). Hepatitis B and C are highly prevalent diseases in Pakistan. Multiple studies showed an increased prevalence of these infections in blood donors [21-24]. Other causes indicated by our study include syphilis, active infection, and some rare disorders like thrombocytosis, polycythemia, malaria, and tuberculosis. In contrast to our study, Valerian et al showed syphilis as the second most common cause of temporary deferral, following anemia. The rates were relatively higher as compared to our study (9.3% versus 8.3%) [12].

This study has some limitations. As this was conducted in a single center in Pakistan, so the findings cannot be generalized. But as shown by Gillet et al., using different questionnaires and a careful review of blood donor deferrals, we can revamp the process of donor selection.
 

Conclusions

In conclusion, blood screening deferral is a significant problem in our region. The most common cause of deferral found in our study was low hemoglobin, followed by infections like hepatitis C, hepatitis B, and syphilis. Other less common causes include early donation, thrombocytosis, polycythemia, pancytopenia, malaria, allergies, insulin, and tuberculosis. Thorough screening and evaluation of blood donors are essential for a safe blood transfusion. 
 


References

  1. Klein HG, Spahn DR, Carson JL: Red blood cell transfusion in clinical practice. Lancet. 2007, 370:415-426. 10.1016/S0140-6736(07)61197-0
  2. Kolte D, Beale C, Aronow HD, et al.: Trends and outcomes of red blood cell transfusion in patients undergoing transcatheter aortic valve replacement in the United States. J Thorac Cardiovasc Surg. 2019, 5223:30717-2. 10.1016/j.jtcvs.2019.03.043
  3. Amrein K, Valentin A, Lanzer G, Drexler C: Adverse events and safety issues in blood donation—a comprehensive review. Blood Rev. 2012, 26:33-42. 10.1016/j.blre.2011.09.003
  4. Williamson LM, Devine DV: Challenges in the management of the blood supply. Lancet. 2013, 381:1866-75. 10.1016/S0140-6736(13)60631-5
  5. Holsworth RE Jr., Cho YI, Weidman JJ, Sloop GD, St Cyr JA: Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables. Perfusion. 2014, 29:102-116. 10.1177/0267659113505637
  6. Kamhieh-Milz S, Kamhieh-Milz J, Tauchmann Y, et al.: Regular blood donation may help in the management of hypertension: an observational study on 292 blood donors. Transfusion. 2016, 56:637-44. 10.1111/trf.13428
  7. Fernández-Real JM, Manco M: Effects of iron overload on chronic metabolic diseases. Lancet Diabetes Endocrinol. 2014, 2:513-26. 10.1016/S2213-8587(13)70174-8
  8. Zacharski LR, Chow BK, Howes PS, et al.: Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008, 100:996-1002. 10.1093/jnci/djn209
  9. Global status report on blood safety and availability 2016. Geneva: World Health Organization. (2017). Accessed: January 2, 2020: https://apps.who.int/iris/bitstream/handle/10665/254987/9789241565431-eng.pdf;jsessionid=3A52D8BA3697425C33ED695DC96E....
  10. Shrivastava M, Shah N, Navaid S, Agarwal K, Sharma G: Blood donor selection and deferral pattern as an important tool for blood safety in a tertiary care hospital. Asian J Transfus Sci. 2016, 10:122-6. 10.4103/0973-6247.187938
  11. Gillet P, Neijens E: An original approach to evaluating the quality of blood donor selection: checking donor questionnaires and analyzing donor deferral rate. Front Med (Lausanne). 2018, 5:74. 10.3389/fmed.2018.00074
  12. Valerian DM, Mauka WI, Kajeguka DC, Mgabo M, Juma A, Baliyima L, Sigalla GN: Prevalence and causes of blood donor deferrals among clients presenting for blood donation in northern Tanzania. PLoS One. 2018, 13:e0206487. 10.1371/journal.pone.0206487
  13. Zou S, Musavi F, Notari EP, Rios JA, Trouern-Trend J, Fang CT: Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. Transfusion. 2008, 48:2531-9. 10.1111/j.1537-2995.2008.01903.x
  14. Sultan S, Irfan SM, Baig MA, Usman SM, Shirazi UA: Insight into donor deferral pattern based on peripheral blood counts: an experience from South Pakistan. Asian J Transfus Sci. 2017, 11:151-155. 10.4103/0973-6247.214357
  15. Agnihotri N: Whole blood donor deferral analysis at a center in Western India. Asian J Transfus Sci. 2010, 4:116-22. 10.4103/0973-6247.67035
  16. Rabeya Y, Rapiaah M, Rosline H, Ahmed SA, Zaidah WA, Roshan TM: Blood pre-donation deferrals--a teaching hospital experience. Southeast Asian J Trop Med Public Health. 2008, 39:571-4.
  17. Waheed U, Zaheer HA: Evaluation of deferral pattern among the blood donors in Islamabad, Pakistan. Glob J Transfus Med. 2016, 1:81-4.
  18. Jamal S, Shaikh I, Sohail S, Ata U, Ali A, Saleem S: Frequency and causes of deferral amongst voluntary non‐remunerated blood donors from Pakistan - a single‐centre study. ISBT Sci Ser. 2018, 13:136-140. 10.1111/voxs.12411
  19. Mast AE: Low hemoglobin deferral in blood donors. Transfus Med Rev. 2014, 28:18-22. 10.1016/j.tmrv.2013.11.001
  20. Mast AE, Schlumpf KS, Wright DJ, et al.: Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion. 2010, 50:1794-802. 10.1111/j.1537-2995.2010.02649.x
  21. Attaullah S, Khan S, Khan J: Trend of transfusion transmitted infections frequency in blood donors: a road map for its prevention and control. J Transl Med. 2012, 10:10.1186/1479-5876-10-20
  22. Nazar H, Nadia N, Shazia N, Zulfiqar A, Farhat A: Prevalence of hepatitis B and C in blood donors of Karachi. Biomedica. 2008, 24:116-117.
  23. Mujeeb SA, Mehmood K: Prevalence of HBV, HCV and HIV infections among family blood donors. Ann Saudi Med. 1996, 16:702-703. 10.5144/0256-4947.1996.702
  24. Sultan F, Mehmood T, Mahmood MT: Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Intern J Infect Dis. 2007, 11:407-412. 10.1016/j.ijid.2006.10.004

Appendices

A sample of the questionnaire used in our study is shown in Figure 1

Original article
peer-reviewed

Frequency and Causes of Deferral among Blood Donors Presenting to Combined Military Hospital Multan


Author Information

Hamid Iqbal

Hematology, Combined Military Hospital Multan, Multan, PAK

Asma Tameez Ud Din Corresponding Author

Hematology, Combined Military Hospital Multan, Multan, PAK

Asim Tameez Ud Din

Internal Medicine, Rawalpindi Medical University, Rawalpindi, PAK

Farooq Mohyud Din Chaudhary

Gastroenterology, Nishtar Medical University & Hospital, Multan, PAK

Muhammad Younas

Chemical Pathology, Combined Military Hospital Multan, Multan, PAK

Abdur Jamil

Internal Medicine, Central Michigan University, Saginaw, USA


Ethics Statement and Conflict of Interest Disclosures

Human subjects: Consent was obtained by all participants in this study. Ethical Committee of CMH Multan issued approval CMH/ERC/2142 Dated 08-12-2017. Research project submitted by Dr. Asma Tameez ud din, postgraduate trainee hematology was reviewed and approved by the Ethical Committee of CMH Multan. . Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.


Original article
peer-reviewed

Frequency and Causes of Deferral among Blood Donors Presenting to Combined Military Hospital Multan


Figures etc.

SIQ
-
RATED BY 1 READER
CONTRIBUTE RATING

Scholary Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. Learn more here.